CELCUITY INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.9 USD | +1.67% |
|
+5.67% | +2.26% |
| 05-31 | Needham Trims Price Target on Celcuity to $23 From $24, Maintains Buy Rating | MT |
| 05-30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELCUITY INC. | Bio Therapeutic Drugs | +1.64% | +5.67% | +2.26% | +33.75% | -32.97% | 515M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- CELC Stock
- Charts Celcuity Inc.
- Comparison Chart
